GARVAN INSTITUTE OF MEDICAL RESEARCH Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70...
Month: <span>September 2020</span>
Post
Customizable synthetic antibiotic outmaneuvers resistant bacteria
UNIVERSITY OF CALIFORNIA – SAN FRANCISCO Antibiotic resistance is one of the world’s most urgent public health threats. In the United States alone, tens of thousands of deaths result each year from drug-resistant strains of common bacteria such as Staphylococcus aureus and Enterococcus faecium, which can cause virtually untreatable hospital-acquired infections. Perilously few new classes...
Post
Experts warn COVID-19 may increase risk of Parkinson’s disease
By Rich Haridy, September 22, 2020 The team of neuroscientists suggest there is evidence catching COVID-19 could increase one’s risk of developing Parkinson’s disease A new article from a team of neuroscientists at the Florey Institute of Neuroscience & Mental Health is warning a future ‘silent wave’ of neurodegenerative disease may be spawned by the...
Post
Immune Protein IL-17A Responsible for Lethal Side Effects of Gastric Cancer
The formation of scar tissue, or fibrosis, as gastric cancer disseminates throughout the peritoneum can be more lethal than the cancer itself and can interfere with chemotherapy. Researchers from Kanazawa University have now found that proinflammatory cytokine IL-17A from mast cells heavily influences the degree of fibrosis and causes structural changes in peritoneal cells. Preventing mast cells...
Post
Computer System Predicts what a Person is Thinking and Displays it as an Image
A group of researchers from the University of Helsinki, Finland, have developed a technique based on EEG data, brain-computer interface technology, and artificial intelligence capable of predicting what a person sees by interpreting brain signals generated at the moment of seeing. The system – called neuroadaptive generative modelling – works via complex interactions between human brain responses...
Post
New vaccine strategy harnesses ‘foot soldier’ T-cells to provide protection against influenza
As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin–Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza. In a study published in Cell Reports Medicine, scientists describe a T-cell-based vaccine strategy that is effective against multiple strains of influenza virus. The...
Post
New Insights into How the Drug Pomalidomide Fights Cancer
Scientists from the Tokyo Institute of Technology, Tokyo Medical University, and Saitama Medical University have published findings that offer insights into how the drug pomalidomide benefits some patients with a cancer called multiple myeloma. Clinicians use pomalidomide to treat cases of multiple myeloma resistant to the more established drug lenalidomide, and the research team found that pomalidomide...
Post
The mysterious cause of stuttering in the brain
After centuries of misunderstanding, research is finally tying the speech disorder to certain genes and brain alterations – and new treatments may be on the horizon. Gerald Maguire has stuttered since childhood, but you might not guess it from talking to him. For the past 25 years, Maguire – a psychiatrist at the University of California, Riverside...
Post
Ultra-low-cost hearing aid could address age-related hearing loss worldwide
by Georgia Institute of Technology Construction and components of the LoCHAid. a. The LoCHAid is shown in its top view, with its 3D printed polyamide (Nylon 12) case tilted. The side view of the audio jack opening and holes for attaching material for neck wear are shown below. The LoCHAid in its case has a size...
Post
HIV drugs could prevent diabetes, study suggests
UNIVERSITY OF VIRGINIA HEALTH SYSTEM IMAGE: JAYAKRISHNA AMBATI, MD, AND COLLEAGUES FOUND THAT PATIENTS TAKING DRUGS CALLED NRTIS TO TREAT HIV AND HEPATITIS B HAD A 33% LOWER RISK OF DEVELOPING DIABETES. A group of drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes, a new study suggests. ...